A Phase II study of carboplatin plus docetaxel in men with metastatic hormone refractory prostate cancer who are refractory to docetaxel
Publication
, Journal Article
Ross, RW; Beer, TM; Jacobus, S; Bubley, GT; Taplin, M-E; Ryan, C; Huang, J; Oh, WK
Published in: Cancer
2008
Duke Scholars
Published In
Cancer
Publication Date
2008
Volume
112
Start / End Page
521 / 526
Related Subject Headings
- Oncology & Carcinogenesis
- 4206 Public health
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Ross, R. W., Beer, T. M., Jacobus, S., Bubley, G. T., Taplin, M.-E., Ryan, C., … Oh, W. K. (2008). A Phase II study of carboplatin plus docetaxel in men with metastatic hormone refractory prostate cancer who are refractory to docetaxel. Cancer, 112, 521–526.
Ross, R. W., T. M. Beer, S. Jacobus, G. T. Bubley, M. -. E. Taplin, C. Ryan, J. Huang, and W. K. Oh. “A Phase II study of carboplatin plus docetaxel in men with metastatic hormone refractory prostate cancer who are refractory to docetaxel.” Cancer 112 (2008): 521–26.
Ross RW, Beer TM, Jacobus S, Bubley GT, Taplin M-E, Ryan C, et al. A Phase II study of carboplatin plus docetaxel in men with metastatic hormone refractory prostate cancer who are refractory to docetaxel. Cancer. 2008;112:521–6.
Ross, R. W., et al. “A Phase II study of carboplatin plus docetaxel in men with metastatic hormone refractory prostate cancer who are refractory to docetaxel.” Cancer, vol. 112, 2008, pp. 521–26.
Ross RW, Beer TM, Jacobus S, Bubley GT, Taplin M-E, Ryan C, Huang J, Oh WK. A Phase II study of carboplatin plus docetaxel in men with metastatic hormone refractory prostate cancer who are refractory to docetaxel. Cancer. 2008;112:521–526.
Published In
Cancer
Publication Date
2008
Volume
112
Start / End Page
521 / 526
Related Subject Headings
- Oncology & Carcinogenesis
- 4206 Public health
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis